Päivi Östling

Päivi Östling

Principal Researcher
Telephone: +46852482304
Visiting address: SciLifeLab, Tomtebodavägen 23a, 17121 Solna
Postal address: K7 Onkologi-Patologi, K7 Forskning Kallioniemi Östling, 171 77 Stockholm

About me

  • I am a biochemist by training, now focusing on precision medicine research
    and implementation. My motivation lies in my deep wish to safely implement
    our technological advances to benefit patients.
    Päivi Östling has more than 10 years of research experience in the field of
    precision cancer medicine (PCM) research. As of 2016, she has been
    responsible for establishing a functional precision medicin (fPM) platform at
    SciLifeLab through the Olli Kallioniemi research group where she also acts as
    a co-principal investigator. The groups research focuses on individualized
    drug profiling including multi-omics in acute myeloid leukemia, ovarian and
    bladder cancer as well as pediatric tumors. She is active within the PCM
    program of KI and since June 2021, she is one of the Scientific Leads of
    Precision Medicine at SciLifeLab.
    2023 National infrastructure to support clinical trials in precision
    medicine with cutting edge technologies, Vetenskapsrådet
    2022 Testing and Experimenting Facility Health
    (TEF-Health) DIGITAL-2022-CLOUD-AI-02
    2022 Building a sustainable European Innovation platform to enhance the
    repurposing of medicine for all - Remedi4all Horizon Europe, Research and
    Innovation Actions. PI of demonstrator project on " Validation drugs and
    combinations for novel host targets in SARS-Cov-2 infection used to build the
    2022 Radiumhemmets forskningsfonder ”Individualied therapy selection for
    muscle invasive bladder cancer”
    2021 Knut and Alice Wallenberg Foundation SciLifeLab National Covid-19
    Research Program: AI-driven drug and target prioritization for Covid-19 in
    collaboration with Charlotte Stadler, Emma Lundberg and Ola Spjuth
    2021 Vinnova testbed grant: Precision care bringing technology innovation
    into oncology (PRIO), PI: Janne Lehtiö
    2021 Miltons donationsfond grant: Spatial single cell maps of bladder cancer
    microenvironment - implications for prognosis and treatment
    2020 Knut and Alice Wallenberg Foundation SciLifeLab National Covid-19
    Research Program: Spatial single-cell mapping of SARS-Cov2 interacting host
    proteins for quick and targeted drug repurposing PI: Charlotte Stadler
    2019 Lillian Sagen och Curt Ericssons fond: A roadmap to a clinical testbed
    for precision cancer medicine
    2018 Vinnova challenge-driven innovation, stage 2: Nanoscale drug testing:
    Sweden as a testbed for revolutionizing drug discovery PI: Olli Kallioniemi,
    project lead Brinton Seashore-Ludlow
    2016 Associate Professor in Biochemical Systems Biology, Faculty of Science
    and Engineering, Åbo Akademi University, Finland
    2006 - 2011 Postdoctoral training, Medical Biotechnology, VTT, Finland
    2006 PhD Turku Centre for Biotechnology, Åbo Akademi University, Finland
    1999 MSc Biochemistry, Faculty of Biochemistry and Pharmacy, Åbo Akademi
    University, Finland


  • My research is on precision cancer medicine in bladder cancer. The aim is to
    link spatial tissue maps with drug sensitivity and molecular profiles to
    understand treatment responses.


All other publications

News from KI

Events from KI